This inventor holds 7 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignee: Fresenius Medical Care Deutschland Gmbh. Active years: 2001-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2018
Title: Wolfgang Kleinekofort: Innovator in Extracorporeal Blood Treatment
Introduction
Wolfgang Kleinekofort is a notable inventor based in Kelkheim, Germany. He has made significant contributions to the field of medical technology, particularly in extracorporeal blood treatment. With a total of 7 patents to his name, Kleinekofort's work has advanced the safety and efficiency of blood monitoring systems.
Latest Patents
Kleinekofort's latest patents include a "Method and device for monitoring an extracorporeal blood circuit." This invention focuses on measuring arterial and venous pressures in the extracorporeal circuit to ensure safe blood treatment. The system calculates the sum and difference of these pressures, indicating potential error states when they fall outside predetermined limits. Another significant patent is the "Device and method for monitoring an access to a patient," which enhances the monitoring of vascular access during blood treatment. This invention utilizes an alternating voltage signal to reduce disturbances caused by movements in the conduits.
Career Highlights
Kleinekofort is currently associated with Fresenius Medical Care Deutschland GmbH, a leading company in the field of renal care and blood treatment technologies. His work has been instrumental in developing innovative solutions that improve patient outcomes in extracorporeal blood treatment.
Collaborations
Kleinekofort has collaborated with notable colleagues such as Christoph König and Andreas Wüpper. Their combined expertise has contributed to the advancement of medical technologies in their field.
Conclusion
Wolfgang Kleinekofort's innovative contributions to extracorporeal blood treatment demonstrate his commitment to improving medical technology. His patents reflect a deep understanding of the complexities involved in blood monitoring and treatment, ultimately enhancing patient safety and care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
